Release of prostaglandin D2 and leukotriene C4 in response to hyperosmolar stimulation of mast cells

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 61, Issue 12, 2006, Pages 1473-1479

  Gulliksson, M ^a   Palmberg, L ^a   Nilsson, G ^a   Ahlstedt, S ^a   Kumlin, M ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Histamine; Immunoglobulin E; Leukotriene C4; Mannitol; Mast cell; Prostaglandin D2

Indexed keywords

CALCIMYCIN; HISTAMINE; ICOSANOID; IMMUNOGLOBULIN E; LEUKOTRIENE C4; MANNITOL; PROSTAGLANDIN D2; HYPERTONIC SOLUTION;

ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; HYPEROSMOLARITY; IN VITRO STUDY; MAST CELL; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; CELL CULTURE; DRUG EFFECT; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

CELLS, CULTURED; HUMANS; HYPERTONIC SOLUTIONS; IMMUNOGLOBULIN E; LEUKOTRIENE C4; MANNITOL; MAST CELLS; PROSTAGLANDIN D2;

EID: 33750531663     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2006.01213.x     Document Type: Article

References (28)

1. Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002;346:1699-1705.
2. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev 1997;77:1033-1079.
3. Eggleston PA, Kagey-Sobotka A, Proud D, Adkinson NF Jr, Lichtenstein LM. Disassociation of the release of histamine and arachidonic acid metabolites from osmotically activated basophils and human lung mast cells. Am Rev Respir Dis 1990;141(4 Pt 1):960-964.
4. 2 in normal and asthmatic men. N Engl J Med 1984;311:209-213.
5. Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001;294:1871-1875.
6. Peters SP, MacGlashan DW Jr, Schulman ES, Schleimer RP, Hayes EC, Rokach J et al. Arachidonic acid metabolism in purified human lung mast cells. J Immunol 1984;132:1972-1979.
7. 2 generation after activation of rat and human mast cells with anti-IgE. J Immunol 1982;129:1627-1631.
8. Anderson SD, Daviskas E. The mechanism of exercise-induced asthma is. J Allergy Clin Immunol 2000;106:453-459.
9. O'Sullivan S, Roquet A, Dahlen B, Larsen F, Eklund A, Kumlin M et al. Evidence for mast cell activation during exercise-induced bronchoconstriction. Eur Respir J 1998;12:345-350.
10. Leff JA, Busse WW, Pearlman D, Bronsky EA, Kemp J, Hendeles L et al. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med 1998;339:147-152.
11. Dahlen B, Roquet A, Inman MD, Karlsson O, Naya I, Anstren G et al. Influence of zafirlukast and loratadine on exercise-induced bronchoconstriction. J Allergy Clin Immunol 2002;109:789-793.
12. Brannan JD, Koskela H, Anderson SD, Chew N. Responsiveness to mannitol in asthmatic subjects with exercise- and hyperventilation-induced asthma. Am J Respir Crit Care Med 1998;158:1120-1126.
13. Brannan JD, Gulliksson M, Anderson SD, Chew N, Kumlin M. Evidence of mast cell activation and leukotriene release after mannitol inhalation. Eur Respir J 2003;22:491-496.
14. Brannan JD, Anderson SD, Gomes K, King GG, Chan HK, Seale JP. Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol. Am J Respir Crit Care Med 2001;163:1420-1425.
15. Brannan JD, Gulliksson M, Anderson SD, Chew N, Seale JP, Kumlin M. Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing. Eur Respir J 2006;27:944-950.
16. Nilsson G, Butterfield JH, Nilsson K, Siegbahn A. Stem cell factor is a chemotactic factor for human mast cells. J Immunol 1994;153:3717-3723.
17. Pradelles P, Grassi J, Maclouf J. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal Chem 1985;57:1170-1173.
18. Maitz MF, Poon RW, Liu XY, Pham MT, Chu PK. Bioactivity of titanium following sodium plasma immersion ion implantation and deposition. Biomaterials 2005;26:5465-5473.
19. Eggleston PA, Kagey-Sobotka A, Schleimer RP, Lichtenstein LM. Interaction between hyperosmolar and IgE-mediated histamine release from basophils and mast cells. Am Rev Respir Dis 1984;130:86-91.
20. Anderson SD, Daviskas E. The airway microvasculature and exercise-induced asthma. Thorax 1992;47:748-752.
21. 4, and histamine in normal human subjects. Thorax 1984;39:500-504.
22. 2 on airway caliber in asthma. J Appl Physiol 1989;66:304-312.
23. Finnerty JP, Wilmot C, Holgate ST. Inhibition of hypertonic saline-induced bronchoconstriction by terfenadine and flurbiprofen. Evidence for the predominant role of histamine. Am Rev Respir Dis 1989;140:593-597.
24. Hsieh FH, Lam BK, Penrose JF, Austen KF, Boyce JA. T helper cell type 2 cytokines coordinately regulate immunoglobulin E-dependent cysteinyl leukotriene production by human cord blood-derived mast cells: profound induction of leukotriene C(4) synthase expression by interleukin 4. J Exp Med 2001;193:123-133.
25. Mellor EA, Austen KF, Boyce JA. Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4regulated pathway that is inhibited by leukotriene receptor antagonists. J Exp Med 2002;195:583-592.
26. Igarashi Y, Kurosawa M, Ishikawa O, Miyachi Y, Saito H, Ebisawa M et al. Characteristics of histamine release from cultured human mast cells. Clin Exp Allergy 1996;26:597-602.
27. Matthews G, Neher E, Penner R. Second messenger-activated calcium influx in rat peritoneal mast cells. J Physiol 1989;418:105-130.
28. Piliponsky AM, Gleich GJ, Nagler A, Bar I, Levi-Schaffer F. Non-IgE-dependent activation of human lungand cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor. Blood 2003;101:1898-1904.